Core decompression isolated or combined with bone marrow-derived cell therapies for femoral head osteonecrosis

References

• Ohzono K, Saito M, Takaoka K, et al. Natural history of nontraumatic avascular necrosis of the femoral head. J Bone Joint Surg Br. 1991 Jan;73(1):68–72.
   PubMedGoogle Scholar
• Lespasio MJ, Sodhi N, Mont MA. Osteonecrosis of the hip: a primer. Perm J. 2019;23:18–100. DOI:10.7812/TPP/18-100
   PubMedGoogle Scholar
• Beckmann R, Shaheen H, Kweider N, et al. Corrigendum to “enoxaparin prevents steroid-related avascular necrosis of the femoral head”. Sci World J. 2015;2015:264241.
   Google Scholar
• Shah KN, Racine J, Jones LC, et al. Pathophysiology and risk factors for osteonecrosis. Curr Rev Musculoskelet Med. 2015 Sep;8(3):201–209.
   PubMed Web of Science ®Google Scholar
• Mankin,HJ. Nontraumatic necrosis of bone (osteonecrosis).N Engl J Med. 1992 May 28;326(22):1473–1479. .
   PubMed Web of Science ®Google Scholar
• Chang CC, Greenspan A, Gershwin ME. Osteonecrosis: current perspectives on pathogenesis and treatment. Semin Arthritis Rheum. 1993 Aug;23(1):47–69.
   PubMed Web of Science ®Google Scholar
• Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head.J Bone Joint Surg Am. 1995 Mar;77(3):459–474.
   PubMed Web of Science ®Google Scholar
• Hernigou P, Beaujean F, Lambotte JC. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br. 1999 Mar;81(2):349–355.
   PubMedGoogle Scholar
• Gangji V, Hauzeur JP, Schoutens A, et al. Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol. 2003 Feb;30(2):348–351.
   PubMed Web of Science ®Google Scholar
• Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res. 1996 Mar;324:169–178.
   PubMedGoogle Scholar
• Pierce TP, Jauregui JJ, Elmallah RK, et al. A current review of core decompression in the treatment of osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015 Sep;8(3):228–232.
   PubMed Web of Science ®Google Scholar
• Ficat P, Arlet J, Vidal R, et al. [Therapeutic results of drill biopsy in primary osteonecrosis of the femoral head (100 cases)]. Rev Rhum Mal Osteoartic. 1971 Apr;38(4):269–276.
   PubMedGoogle Scholar
• Hauzeur JP, Pasteels JL, Orloff S. Bilateral non-traumatic aseptic osteonecrosis in the femoral head. An experimental study of incidence. J Bone Joint Surg Am. 1987 Oct;69(8):1221–1225.
   PubMedGoogle Scholar
• Gao YS, Zhang CQ. Cytotherapy of osteonecrosis of the femoral head: a mini review. Int Orthop. 2010 Aug;34(6):779–782.
   PubMed Web of Science ®Google Scholar
• Lieberman JR, Engstrom SM, Meneghini RM, et al. Which factors influence preservation of the osteonecrotic femoral head? Clin Orthop Relat Res. 2012 Feb;470(2):525–534.
   PubMed Web of Science ®Google Scholar
• Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011 Nov;49(5):1005–1009.
   PubMed Web of Science ®Google Scholar
• Hauzeur JP, De Maertelaer V, Baudoux E, et al. Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. Int Orthop. 2018 Jul;42(7):1429–1435.
   PubMed Web of Science ®Google Scholar
• Sen RK, Tripathy SK, Aggarwal S, et al. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplasty. 2012 May;27(5):679–686.
   PubMed Web of Science ®Google Scholar
• Tabatabaee RM, Saberi S, Parvizi J, et al. Combining concentrated autologous bone marrow stem cells injection with core decompression improves outcome for patients with early-stage osteonecrosis of the femoral head: a comparative study. J Arthroplasty. 2015 Sep;30(9Suppl):11–15.
   PubMedGoogle Scholar
• Zhao D, Cui D, Wang B, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012 Jan;50(1):325–330.
   PubMed Web of Science ®Google Scholar
• Pepke W, Kasten P, Beckmann NA, et al. Core decompression and autologous bone marrow concentrate for treatment of femoral head osteonecrosis: a randomized prospective study. Orthop Rev (Pavia). 2016 Mar 21;8(1):6162.
   PubMed Web of Science ®Google Scholar
• Wu ZY, Sun Q, Liu M, et al. Correlation between the efficacy of stem cell therapy for osteonecrosis of the femoral head and cell viability. BMC Musculoskelet Disord. 2020 [Jan 29];21(1):55. .
   PubMed Web of Science ®Google Scholar
• Kang JS, Suh YJ, Moon KH, et al. Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: a matched pair control study with simple core decompression. Stem Cell Res Ther. 2018 Oct 25;9(1):274.
   PubMedGoogle Scholar
• Li X, Xu X, Wu W. Comparison of bone marrow mesenchymal stem cells and core decompression in treatment of osteonecrosis of the femoral head: a meta-analysis. Int J Clin Exp Pathol. 2014;7(8):5024–5030.
   PubMed Web of Science ®Google Scholar
• Papakostidis C, Tosounidis TH, Jones E, et al. The role of “cell therapy” in osteonecrosis of the femoral head. A systematic review of the literature and meta-analysis of 7 studies. Acta Orthop. 2016 Feb;87(1):72–78.
   PubMed Web of Science ®Google Scholar
• Yuan HF, Zhang J, Guo CA, et al. Clinical outcomes of osteonecrosis of the femoral head after autologous bone marrow stem cell implantation: a meta-analysis of seven case-control studies. Clinics (Sao Paulo). 2016 Feb;71(2):110–113.
   PubMed Web of Science ®Google Scholar
• Xu S, Zhang L, Jin H, et al. Autologous stem cells combined core decompression for treatment of avascular necrosis of the femoral head: a systematic meta-analysis. BioMed Res Int. 2017;2017:6136205.
   PubMed Web of Science ®Google Scholar
• Wang Z, Sun QM, Zhang FQ, et al. Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysis. Int J Surg. 2019 Sep;69:23–31.
   PubMed Web of Science ®Google Scholar
• Hernigou P, Dubory A, Homma Y, et al. Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients. Int Orthop. 2018 Jul;42(7):1639–1649.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009 Jul;339:b2535.
   PubMed Web of Science ®Google Scholar
• J Ci H, Glasziou P, Greenhalgh T, et al. Oxford levels of evidence. Oxford Centre Evidence Based Med. 2011;2011. [cited 2020 Oct]. Available from https://wwwcebmnet/indexaspx?o=5653
   Google Scholar
• Schmitt-Sody M, Kirchhoff C, Mayer W, et al. Avascular necrosis of the femoral head: inter- and intraobserver variations of Ficat and ARCO classifications. Int Orthop. 2008 Jun;32(3):283–287.
   PubMed Web of Science ®Google Scholar
• Sadile F, Bernasconi A, Russo S, et al. Core decompression versus other joint preserving treatments for osteonecrosis of the femoral head: a meta-analysis. Br Med Bull. 2016 Jun;118(1):33–49.
   PubMed Web of Science ®Google Scholar
• Marker DR, Seyler TM, McGrath MS, et al. Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am. 2008 Nov;90(Suppl 4):175–187.
   PubMedGoogle Scholar
• Lieberman JR, Berry DJ, Mont MA, et al. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect. 2003;52:337–355.
   PubMedGoogle Scholar
• Koo KH, Dussault RG, Kaplan PA, et al. Fatty marrow conversion of the proximal femoral metaphysis in osteonecrotic hips. Clin Orthop Relat Res. 1999 [Apr];361:159–167.
   Google Scholar
• Kamal KC, Alexandru DO, Rogoveanu OC, et al. Immunohistochemical analysis of bone metabolism in osteonecrosis of the femoral head. Rom J Morphol Embryol. 2018;59(3):819–824.
   PubMed Web of Science ®Google Scholar
• Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am. 2006 May;88(5): 1117–1132.
   PubMedGoogle Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999 Apr 2;284(5411):143–147.
   PubMed Web of Science ®Google Scholar
• Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood). 2001 Jun;226(6):507–520.
   PubMed Web of Science ®Google Scholar
• Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19(3):180–192.
   PubMed Web of Science ®Google Scholar
• Conway EM. Molecular mechanisms of blood vessel growth.Cardiovasc Res. 2001 Feb 16;49(3):507–521.
   PubMed Web of Science ®Google Scholar
• Yan Z, Hang D, Guo C, et al. Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. J Orthop Res. 2009 Apr;27(4):442–446.
   PubMed Web of Science ®Google Scholar
• Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators.J Cell Biochem. 2006 Aug 1;98(5):1076–1084.
   PubMed Web of Science ®Google Scholar
• Lda S, Fontes AM, Covas DT, et al. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Fact Rev. 2009 Oct-Dec;20(5–6):419–427.
   PubMed Web of Science ®Google Scholar
• Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013 Nov;15(45): e54.
   Google Scholar
• Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007 Oct 19;131(2):324–336.
   PubMed Web of Science ®Google Scholar
• Tzaribachev N, Vaegler M, Schaefer J, et al. Mesenchymal stromal cells: a novel treatment option for steroid-induced avascular osteonecrosis. Isr Med Assoc J. 2008 Mar;10(3):232–234.
   PubMed Web of Science ®Google Scholar
• Hernigou P, Poignard A, Manicom O, et al. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br. 2005 Jul;87(7):896–902.
   PubMedGoogle Scholar
• Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002 Dec;405:14–23.
   PubMed Web of Science ®Google Scholar
• Sommer B, Sattler G. Current concepts of fat graft survival: histology of aspirated adipose tissue and review of the literature. Dermatol Surg. 2000 Dec;26(12):1159–1166.
   PubMed Web of Science ®Google Scholar
• Boschert MT, Beckert BW, Puckett CL et al. Analysis of lipocyte viability after liposuction. Plast Reconstr Surg. 2002 Feb;109(2):761–765. discussion 766-7.
   PubMed Web of Science ®Google Scholar
• Mardones R, Camacho D, Monsalvo F, et al. Treatment of osteonecrosis of the femoral head by core decompression and implantation of fully functional ex vivo-expanded bone marrow-derived mesenchymal stem cells: a proof-of-concept study. Stem Cells Cloning. 2019;12:11–16.
   PubMed Web of Science ®Google Scholar
• Migliorini F, Rath B, Tingart M, et al. Autogenic mesenchymal stem cells for intervertebral disc regeneration. Int Orthop. 2019 Apr;43(4):1027–1036.
   PubMed Web of Science ®Google Scholar
• Migliorini F, Rath B, Colarossi G, et al. Improved outcomes after mesenchymal stem cells injections for knee osteoarthritis: results at 12-months follow-up: a systematic review of the literature. Arch Orthop Trauma Surg. 2019 Aug 27;140(7).
   Web of Science ®Google Scholar